ACTIVE

APOTHEEK VERLINDEN

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result45,5 k €-42,8 %over 1 year

Gross margin470,6 k €-9,2 %over 1 year

Equity666,7 k €+7,3 %over 1 year

Workforce6,3 ETP+12,5 %over 1 year

Identity

Source · BCE/KBO

APOTHEEK VERLINDEN is a Public limited company incorporated in 1986. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Antwerpen. It employs on average 6,3 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0429.633.487
Incorporation: 20/10/1986
Legal form: Public limited company
Registered office: Putsebaan 24
2040 Antwerpen · FlandreSee on map
Contributed capital: 177 000,00 €
Latest accounts: 31/12/2025
Average workforce: 6,3 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation

Joint committees (2)

313
31300

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 19 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	470,6 k €	-9.2%	518,2 k €	+63.0%	318 k €	-21.6%	405,4 k €	-56.0%	920,4 k €
EBITDA	92,6 k €	-26.8%	126,5 k €	+230%	-97,4 k €	-525%	22,9 k €	-96.0%	578,5 k €
Operating result	52,3 k €	-39.8%	87 k €	+162%	-139,9 k €	-966%	-13,1 k €	-102%	531 k €
Net result	45,5 k €	-42.8%	79,7 k €	+155%	-144,3 k €	-3280%	4,5 k €	-98.9%	399,9 k €
Balance sheet
Equity	666,7 k €	+7.3%	621,1 k €	+14.7%	541,5 k €	-21.0%	685,8 k €	+0.7%	681,2 k €
Total assets	910,6 k €	+3.0%	883,6 k €	+3.3%	855,4 k €	-19.4%	1,1 M €	-64.5%	3 M €
Cash	61,9 k €	-42.1%	107 k €	-8.2%	116,5 k €	-62.0%	306,7 k €	-50.2%	616 k €
Debts	241,6 k €	-8.0%	262,5 k €	-16.4%	313,9 k €	-16.4%	375,7 k €	-83.7%	2,3 M €
Other
Workforce	6,3 ETP	+12.5%	5,6 ETP	-12.5%	6,4 ETP	+16.4%	5,5 ETP	0.0%	5,5 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 5 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
ANTWERP PHARMACIES0700.733.344Represented by Joris MEES	Managing directorsince 01/02/2023Directorlisted until the 2022 accountsended
Jeff Roskams Consulting0699.953.483Represented by Jeff ROSKAMS	Directorsince 31/01/2023

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
EDULINGE0893.829.660Represented by Mark Weyns	Director28/06/2019 → 2021 accounts
Inge Verlinden	Managing director30/06/2017 → 2019 accountsDirector30/06/2016 → 2020 accounts

Other companies at this address

Putsebaan 24 2040 Antwerpen

Company	CBE no.
Apoteken Verlinden-Cuypers● Liquidation	0404.808.615

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	02/07/2026	07/07/2025	08/07/2024	21/07/2023	05/08/2022	30/08/2021
General meeting	30/06/2026	30/06/2025	29/06/2024	30/06/2023	30/06/2022	30/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	30/06/2026	02/07/2026	Dutch	PDF
Abridged model	31/12/2024	30/06/2025	07/07/2025	Dutch	PDF
Abridged model	31/12/2023	29/06/2024	08/07/2024	Dutch	PDF
Abridged model	31/12/2022	30/06/2023	21/07/2023	Dutch	PDF
Abridged model	31/12/2021	30/06/2022	05/08/2022	Dutch	PDF
Abridged model	31/12/2020	30/06/2021	30/08/2021	Dutch	PDF
Abridged model	31/12/2019	30/06/2020	07/08/2020	Dutch	PDF
Abridged model	31/12/2018	31/07/2019	20/08/2019	Dutch	PDF
Abridged model	31/12/2017	29/06/2018	02/08/2018	Dutch	PDF
Abridged model	31/12/2016	30/06/2017	31/07/2017	Dutch	PDF
Abridged model	31/12/2015	30/06/2016	04/07/2016	Dutch	PDF
Abridged model	31/12/2014	30/06/2015	28/08/2015	Dutch	PDF
Abridged model	31/12/2013	30/06/2014	17/07/2014	Dutch	PDF
Abridged model	31/12/2012	29/06/2013	02/07/2013	Dutch	PDF
Abridged model	31/12/2011	30/06/2012	02/07/2012	Dutch	PDF
Abridged model	31/12/2010	30/06/2011	22/08/2011	Dutch	PDF
Abridged model	31/12/2009	30/06/2010	13/07/2010	Dutch	PDF
Abridged model	31/12/2008	30/06/2009	01/07/2009	Dutch	PDF
Abridged model	31/12/2007	30/06/2008	03/07/2008	Dutch	PDF
Abridged model	31/12/2006	18/06/2007	25/06/2007	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 5 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
ANTWERP PHARMACIES0700.733.344Represented by Joris MEES	Managing directorsince 01/02/2023Directorlisted until the 2022 accountsended
Jeff Roskams Consulting0699.953.483Represented by Jeff ROSKAMS	Directorsince 31/01/2023

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
EDULINGE0893.829.660Represented by Mark Weyns	Director28/06/2019 → 2021 accounts
Inge Verlinden	Managing director30/06/2017 → 2019 accountsDirector30/06/2016 → 2020 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Capital / shares30/10/2023
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - BENAMING - DOEL - KAPITAAL - AANDELEN
PDF
Mandates14/04/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates24/08/2022
ONTSLAGEN - BENOEMINGEN
PDF
Mandates05/03/2020
ONTSLAGEN - BENOEMINGEN
PDF
Mandates05/08/2019
ONTSLAGEN - BENOEMINGEN
PDF
Mandates04/05/2017
ontslag bestuurder
PDF
Mandates01/04/2014
benoeming bestuurder
PDF
Mandates22/06/2012
ONTSLAGEN - BENOEMINGEN
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings19 filings

Mandates

Jeff Roskams Consulting

ANTWERP PHARMACIES

EDULINGE

Inge Verlinden

Eduard Verlinden

Lucia Cuypers

An Verlinden

19861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026

APOTHEEK VERLINDENApoteek Verlinden

Putsebaan 24, 2040 Antwerp-2040

Director

Managing director

Director

Managing directorDirector

DirectorManaging director

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Putsebaan 24, 2040 Antwerp-2040Current	accounts 2021 → 2025	Accounts 2025 · 2026-00243592

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
APOTHEEK VERLINDENCurrent	accounts 2023 → 2025	Accounts 2025 · 2026-00243592
Apoteek Verlinden	accounts 2006 → 2022	Accounts 2022 · 2023-00258197

Events

2025
Annual accounts 202545,5 k €↓
2024
Annual accounts 202479,7 k €↑
2023
Annual accounts 2023-144,3 k €↓
2023
Name changeAPOTHEEK VERLINDEN
2022
Annual accounts 20224,5 k €↓
2021
Annual accounts 2021399,9 k €↑
2019
Annual accounts 201933,8 k €↑
2018
Annual accounts 201827 k €↓
2017
Annual accounts 201739,7 k €↓
2016
Annual accounts 201669,8 k €↓
2015
Annual accounts 2015162,2 k €↑
2014
Annual accounts 201468,2 k €↓
2013
Annual accounts 201386,3 k €↓
2012
Annual accounts 2012108,2 k €↓
2011
Annual accounts 2011152,7 k €↓
2010
Annual accounts 2010154,5 k €↑
2009
Annual accounts 2009132,2 k €↓
2008
Annual accounts 2008134 k €↑
2007
Annual accounts 2007103,6 k €↓
2006
Annual accounts 2006113 k €
20/10/1986
IncorporationPublic limited company

APOTHEEK VERLINDEN

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events